Seelos Therapeutics, Inc. (SEEL): Price and Financial Metrics
GET POWR RATINGS... FREE!
SEEL Stock Price Chart Interactive Chart >
SEEL Price/Volume Stats
| Current price | $0.59 | 52-week high | $3.59 |
| Prev. close | $0.58 | 52-week low | $0.48 |
| Day low | $0.58 | Volume | 685,756 |
| Day high | $0.61 | Avg. volume | 1,627,808 |
| 50-day MA | $0.72 | Dividend yield | N/A |
| 200-day MA | $1.48 | Market Cap | 63.11M |
Seelos Therapeutics, Inc. (SEEL) Company Bio
Seelos Therapeutics, Inc. operates as a biotechnology company. The Company develops treatments for post-traumatic stress and major depressive disorders. Seelos Therapeutics serves patients in the United States.
Latest SEEL News From Around the Web
Below are the latest news stories about Seelos Therapeutics Inc that investors may wish to consider to help them evaluate SEEL as an investment opportunity.
Psychedelic Stock Gainers And Losers From February 24, 2022GAINERS: Seelos Therapeutics (NASDAQ: SEEL ) shares closed up 11.06% at $1.10 Mind Medicine (NASDAQ: MNMD ) shares closed up 11.01% at $1.21 Compass Pathways (NASDAQ: CMPS ) shares closed up 4.50% at $13.23 ATAI Life Sciences (NASDAQ: ATAI ) shares closed up 3.83% at $5.42 Mindset Pharma (OTC: Full story available on Benzinga.com |
B.Riley Financial Thinks Seelos Therapeutics’ Stock is Going to RecoverB.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Seelos Therapeutics (SEEL – Research Report) today and set a price target of $6.00. The company's shares closed last Wednesday at $1.20, close to its 52-week low of $1.00. According to TipRanks.com, Mamtani has 0 stars on 0-5 stars ranking scale with an average return of -19.6% and a 28.4% success rate. Mamtani covers the Healthcare sector, focusing on stocks such as Arrowhead Pharmaceuticals, Spectrum Pharmaceuticals, and Madrigal Pharmaceuticals. Seelos Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $6.00. |
Field Trip Health, Seelos Therapeutics Among Top Psychedelic Movers Of TodayGAINERS: Small Pharma (OTC: Full story available on Benzinga.com |
Psychedelic Stock Gainers And Losers From January 20, 2022GAINERS: Small Pharma (OTC: DMTTF ) shares closed up 14.55% at $0.21 GH Research (NASDAQ: GHRS ) shares closed up 3.35% at $16.99 Field Trip Health (NASDAQ: FTRP ) shares closed up 2.00% at $2.04 LOSERS: Mindset Pharma (OTC: MSSTF ) shares closed down -4.33% at $0.57 Seelos Therapeutics (NASDAQ: SEEL ) shares closed down Full story available on Benzinga.com |
Seelos Therapeutics, Inc. (NASDAQ:SEEL) Expected to Post Earnings of -$0.12 Per ShareBrokerages forecast that Seelos Therapeutics, Inc. (NASDAQ:SEEL) will report earnings per share of ($0.12) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Seelos Therapeutics earnings. The highest EPS estimate is ($0.11) and the lowest is ($0.12). Seelos Therapeutics posted earnings per share of ($0.13) during the same [] |
SEEL Price Returns
| 1-mo | -8.63% |
| 3-mo | -44.34% |
| 6-mo | -68.11% |
| 1-year | -80.84% |
| 3-year | -77.65% |
| 5-year | -97.93% |
| YTD | -63.80% |
| 2021 | 3.16% |
| 2020 | 17.91% |
| 2019 | -76.74% |
| 2018 | -89.57% |
| 2017 | 41.54% |
Loading social stream, please wait...